SCHEMBL2812960

SCHEMBL2812960

COc1cc(CNc2nc3c4c(n[nH]c4n2)CCN3Cc2ccccc2)cc(OC)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLPP Q16740 1/20 0.40
SIGMAR1 Q99720 3/20 0.39
TLR7 Q9NYK1 2/20 0.38
HRH1 P35367 3/20 0.37
HRH4 Q9H3N8 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 1/20 0.36
HTT P42858 1/20 0.35
HIF1A Q16665 1/20 0.35
MAPT P10636 1/20 0.35
SLC2A1 P11166 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ACHE P22303 1/20 0.35
BACE1 P56817 1/20 0.35
ROCK2 O75116 1/20 0.35
ROCK1 Q13464 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2812210 0.93 SIGMAR1 (0.46) CLPPSIGMAR1TLR7KDM4EGAA
SCHEMBL2813023 0.93 CLPP (0.38) CLPPSIGMAR1TLR7HRH1HRH4
SCHEMBL537583 0.91 CLPP (0.49) CLPPSIGMAR1TLR7HRH1HRH4
SCHEMBL2809435 0.89 ACHE (0.45) SIGMAR1KDM4EGAAALDH1A1MAPT
SCHEMBL2811109 0.88 SIGMAR1 (0.43) CLPPSIGMAR1MAPTACHEROCK2
SCHEMBL2811941 0.88 CLPP (0.41) CLPPHRH1HRH4KDM4EGAA
SCHEMBL2816678 0.87 CYP1A2 (0.46) TLR7GAAKMT2AACHE
SCHEMBL2813934 0.86 CLPP (0.42) CLPPSIGMAR1TLR7HRH1HRH4
SCHEMBL2810268 0.86 CLPP (0.42) CLPPSIGMAR1TLR7HRH1HRH4
SCHEMBL2812343 0.86 CLPP (0.45) CLPPSIGMAR1TLR7HRH1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 CLPP 2832/4885SIGMAR1 4535/4885TLR7 3602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.